Prosight Management as of Sept. 30, 2023
Portfolio Holdings for Prosight Management
Prosight Management holds 41 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pacira Pharmaceuticals (PCRX) | 11.8 | $37M | 1.2M | 30.68 | |
| Humana (HUM) | 10.0 | $32M | 65k | 486.52 | |
| Galapagos Nv Spon Adr (GLPG) | 8.0 | $25M | 730k | 34.55 | |
| Meiragtx Holdings (MGTX) | 6.3 | $20M | 4.1M | 4.91 | |
| Kura Oncology (KURA) | 5.6 | $18M | 1.9M | 9.12 | |
| BioCryst Pharmaceuticals (BCRX) | 5.4 | $17M | 2.4M | 7.08 | |
| Oric Pharmaceuticals (ORIC) | 4.9 | $16M | 2.6M | 6.05 | |
| Medtronic SHS (MDT) | 3.7 | $12M | 150k | 78.36 | |
| Abcellera Biologics (ABCL) | 3.6 | $11M | 2.4M | 4.60 | |
| Mirum Pharmaceuticals (MIRM) | 3.5 | $11M | 354k | 31.60 | |
| Neurocrine Biosciences (NBIX) | 2.9 | $9.0M | 80k | 112.50 | |
| Inari Medical Ord | 2.7 | $8.5M | 130k | 65.40 | |
| Inspire Med Sys (INSP) | 2.5 | $7.9M | 40k | 198.44 | |
| Option Care Health Com New (OPCH) | 2.3 | $7.1M | 220k | 32.35 | |
| Quidel Corp (QDEL) | 2.0 | $6.2M | 85k | 73.04 | |
| Prothena Corp SHS (PRTA) | 1.9 | $6.1M | 126k | 48.25 | |
| Nanostring Technologies (NSTGQ) | 1.9 | $5.9M | 3.4M | 1.72 | |
| Dex (DXCM) | 1.8 | $5.8M | 62k | 93.30 | |
| Kezar Life Sciences | 1.8 | $5.7M | 4.8M | 1.19 | |
| Centene Corporation (CNC) | 1.7 | $5.5M | 80k | 68.88 | |
| Universal Hlth Svcs CL B (UHS) | 1.6 | $5.1M | 41k | 125.73 | |
| Adc Therapeutics Sa SHS (ADCT) | 1.5 | $4.8M | 5.4M | 0.90 | |
| Teladoc (TDOC) | 1.5 | $4.6M | 250k | 18.59 | |
| Masimo Corporation (MASI) | 1.1 | $3.5M | 40k | 87.68 | |
| Graphite Bio | 1.1 | $3.3M | 1.3M | 2.48 | |
| Irhythm Technologies (IRTC) | 1.0 | $3.3M | 35k | 94.26 | |
| Penumbra (PEN) | 1.0 | $3.3M | 14k | 241.91 | |
| Shattuck Labs (STTK) | 1.0 | $3.2M | 2.1M | 1.52 | |
| Design Therapeutics (DSGN) | 0.9 | $2.8M | 1.2M | 2.36 | |
| Barrett Business Services (BBSI) | 0.6 | $1.9M | 21k | 90.24 | |
| Compass Therapeutics (CMPX) | 0.6 | $1.8M | 935k | 1.97 | |
| Alkermes SHS (ALKS) | 0.6 | $1.8M | 65k | 28.01 | |
| Longboard Pharmaceuticals In | 0.6 | $1.8M | 321k | 5.56 | |
| Nuvation Bio Com Cl A (NUVB) | 0.4 | $1.4M | 1.1M | 1.34 | |
| Agilon Health (AGL) | 0.4 | $1.4M | 79k | 17.76 | |
| Biomea Fusion (BMEA) | 0.4 | $1.3M | 95k | 13.76 | |
| Chemed Corp Com Stk (CHE) | 0.4 | $1.3M | 2.5k | 519.70 | |
| Evolus (EOLS) | 0.4 | $1.2M | 127k | 9.14 | |
| Zymeworks Del (ZYME) | 0.2 | $675k | 106k | 6.34 | |
| Erasca (ERAS) | 0.2 | $522k | 265k | 1.97 | |
| Elutia Cl A Com (ELUT) | 0.0 | $37k | 26k | 1.43 |
